Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02492126 · ClinicalTrials.gov registry record
Esophageal Motility in Reflux Induced Cough
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 87
- Enrollment target
NCT02492126: Completed study, sponsored by Mayo Clinic.
NCT02492126 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02492126 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
To determine whether contraction abnormalities in the esophagus plays a role in gastroesophageal reflux induced cough, and thus cough severity in patients with chronic cough.
Interventions
- OTHER Citric Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-06 |
What the finished NCT02492126 record still lists
NCT02492126 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Citric Acid is the first listed.
NCT02492126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02492126 about?
NCT02492126 is a clinical study titled "Esophageal Motility in Reflux Induced Cough". To determine whether contraction abnormalities in the esophagus plays a role in gastroesophageal reflux induced cough, and thus cough severity in patients with chronic cough.
What is the current status of trial NCT02492126?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2016-01. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02492126?
The interventions under investigation include: Citric Acid (OTHER).
Who is sponsoring clinical trial NCT02492126?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia